JP2001524084A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001524084A5 JP2001524084A5 JP1998544247A JP54424798A JP2001524084A5 JP 2001524084 A5 JP2001524084 A5 JP 2001524084A5 JP 1998544247 A JP1998544247 A JP 1998544247A JP 54424798 A JP54424798 A JP 54424798A JP 2001524084 A5 JP2001524084 A5 JP 2001524084A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/842,756 | 1997-04-17 | ||
| US08/842,756 US6656508B2 (en) | 1997-04-17 | 1997-04-17 | Sustained-release alginate gels |
| PCT/US1998/007566 WO1998046211A1 (en) | 1997-04-17 | 1998-04-14 | Sustained-release alginate gels |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001524084A JP2001524084A (ja) | 2001-11-27 |
| JP2001524084A5 true JP2001524084A5 (https=) | 2005-11-10 |
Family
ID=25288180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP54424798A Ceased JP2001524084A (ja) | 1997-04-17 | 1998-04-14 | 持続放出性アルギネートゲル |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6656508B2 (https=) |
| EP (1) | EP0975333B1 (https=) |
| JP (1) | JP2001524084A (https=) |
| AT (1) | ATE354351T1 (https=) |
| AU (1) | AU6973498A (https=) |
| CA (1) | CA2286092C (https=) |
| DE (1) | DE69837140T2 (https=) |
| DK (1) | DK0975333T3 (https=) |
| ES (1) | ES2283052T3 (https=) |
| PT (1) | PT975333E (https=) |
| TW (1) | TW577755B (https=) |
| WO (1) | WO1998046211A1 (https=) |
| ZA (1) | ZA983089B (https=) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL117175A (en) | 1995-02-20 | 2005-11-20 | Sankyo Co | Osteoclastogenesis inhibitory factor protein |
| US7022683B1 (en) | 1998-05-13 | 2006-04-04 | Carrington Laboratories, Inc. | Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation |
| AU2003200609B2 (en) * | 1998-05-18 | 2006-02-23 | Amgen Inc. | Biodegradable sustained-release alginate gels |
| US6432449B1 (en) * | 1998-05-18 | 2002-08-13 | Amgen Inc. | Biodegradable sustained-release alginate gels |
| ES2253851T3 (es) | 1998-08-07 | 2006-06-01 | Curis, Inc. | Composicion farmaceutica estable de proteinas hedgehog y uso de la misma. |
| HUP0104126A3 (en) * | 1998-10-28 | 2004-07-28 | Sankyo Company Ltd Chuo Ku | Remedies for bone metabolic errors |
| KR100845769B1 (ko) * | 1999-02-03 | 2008-07-11 | 파우더젝트 리서치 리미티드 | 하이드로겔 입자 제제 |
| EP1158961A1 (en) * | 1999-03-08 | 2001-12-05 | PowderJect Research Limited | Delivery of microparticle formulations using needleless syringe device for sustained-release of bioactive compounds |
| US6458387B1 (en) * | 1999-10-18 | 2002-10-01 | Epic Therapeutics, Inc. | Sustained release microspheres |
| EP1537860A1 (en) * | 2000-05-12 | 2005-06-08 | Pharmacia & Upjohn Company LLC | Vaccine composition, method of preparing the composition and method of vaccinating vertebrates |
| ES2243497T3 (es) * | 2000-05-12 | 2005-12-01 | PHARMACIA & UPJOHN COMPANY LLC | Composicion de vacuna, procedimiento de preparacion de la misma y procedimiento para vacunacion de vertebrados. |
| US20030022856A1 (en) * | 2001-01-30 | 2003-01-30 | The Regents Of The University Of Michigan | Method for sustained release local delivery of drugs for ablation of unwanted tissue |
| US7494669B2 (en) | 2001-02-28 | 2009-02-24 | Carrington Laboratories, Inc. | Delivery of physiological agents with in-situ gels comprising anionic polysaccharides |
| EP1270015A3 (en) * | 2001-06-29 | 2004-02-25 | Sankyo Company Limited | A complex comprising OCIF and Polysaccharide |
| JP2003081865A (ja) * | 2001-09-12 | 2003-03-19 | Ltt Institute Co Ltd | 水不溶性徐放性組成物、その製剤及びその製造方法 |
| US20040005999A1 (en) * | 2002-03-07 | 2004-01-08 | Andreasen Kasper Huus | Polyamino acid-based particle insulin preparation |
| US6840196B2 (en) | 2002-03-13 | 2005-01-11 | Aspen Pet Products, Inc. | Rawhide pet chew |
| US6984403B2 (en) * | 2003-12-04 | 2006-01-10 | Pfizer Inc. | Azithromycin dosage forms with reduced side effects |
| US8112400B2 (en) * | 2003-12-23 | 2012-02-07 | Texas Instruments Incorporated | Method for collecting data from semiconductor equipment |
| FI116625B (fi) * | 2004-01-28 | 2006-01-13 | Macrocrystal Oy | Menetelmä proteiinien kiteyttämiseksi hiilihydraattirunkoisilla polymeereillä |
| EP1781282A4 (en) * | 2004-07-23 | 2010-09-01 | Dpi Solutions Inc | COMPOSITION FOR STABILIZING VITAMIN C IN WATER PHASE AND THIS USE METHOD FOR STABILIZING VITAMIN C |
| CA2583308C (en) * | 2004-10-08 | 2020-01-07 | Georgia Tech Research Corporation | Microencapsulation of cells in hydrogels using electrostatic potentials |
| EP1799232B1 (en) | 2004-10-12 | 2015-10-07 | FMC Biopolymer AS | Self-gelling alginate systems and uses thereof |
| US20060099550A1 (en) * | 2004-11-10 | 2006-05-11 | Ranir/Dcp Corporation | Device and method for delivering an oral care agent |
| CA2615173C (en) | 2005-07-14 | 2012-01-03 | Lipothera, Inc. | Sustained release enhanced lipolytic formulation for regional adipose tissue treatment |
| US20070116680A1 (en) * | 2005-11-18 | 2007-05-24 | Rensselaer Polytechnic Institute | Stem cells within gel microenvironments |
| TWI285100B (en) * | 2005-12-27 | 2007-08-11 | Ind Tech Res Inst | Surface modification of polysaccharide, the modified polysaccharide, and method of culturing and recovery cells using the same |
| WO2007146319A2 (en) * | 2006-06-13 | 2007-12-21 | Symphony Medical, Inc. | Methods and apparatus for using polymer-based beads and hydrogels for cardiac applications |
| JP2010506941A (ja) * | 2006-10-17 | 2010-03-04 | リセラ，インク． | 甲状腺眼症の治療のための方法、組成物及び製剤 |
| GB0624227D0 (en) * | 2006-12-05 | 2007-01-10 | Common Services Agency | Protein purification |
| JP5162134B2 (ja) * | 2007-01-22 | 2013-03-13 | 愛媛県 | 機能性材料の製造方法、機能性材料、シート状構造体、及び衛生製品 |
| WO2008118387A2 (en) * | 2007-03-23 | 2008-10-02 | Wayne State University | Erythrocyte atp-release modulators |
| CN103463638A (zh) * | 2007-08-28 | 2013-12-25 | Fmc有限公司 | 延迟的自胶凝藻酸盐体系及其应用 |
| EP2207568B1 (en) | 2007-11-16 | 2017-05-31 | The Rockefeller University | Antibodies specific for the protofibril form of beta-amyloid protein |
| CN102438657A (zh) * | 2009-03-26 | 2012-05-02 | 沃萨乌整形外科公司 | 鉴别定向药物递送组合物的潜在组分的方法 |
| US9132084B2 (en) | 2009-05-27 | 2015-09-15 | Neothetics, Inc. | Methods for administration and formulations for the treatment of regional adipose tissue |
| GB2487868B (en) * | 2010-01-15 | 2014-12-10 | Neothetics Inc | Lyophilized cake formulations |
| EP2590605A1 (en) | 2010-07-09 | 2013-05-15 | Board of Regents of the University of Texas System | Biodegradable scaffolds |
| UA111822C2 (uk) | 2010-11-24 | 2016-06-24 | Общєство С Огранічєнной Отвєтствєнностью "Новамедіка" | Монотерапевтичий препарат селективного ліпофільного бета-агоніста тривалої дії і спосіб косметичного лікування ожиріння і контурного випинання |
| GB201120368D0 (en) | 2011-11-24 | 2012-01-04 | Sperm Vital As | Methods for the preparation of hydrogels |
| CN103830266A (zh) * | 2013-04-24 | 2014-06-04 | 杨亚勤 | 部分氧化海藻酸钠羧甲基化衍生物的制备方法和应用 |
| US10383825B2 (en) | 2015-08-13 | 2019-08-20 | Temple University—Of the Commonwealth System of Higher Education | Calcium alginate dosage formulations, and methods of making and using thereof |
| US10729771B2 (en) | 2016-02-10 | 2020-08-04 | Rutgers, The State University Of New Jersey | Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of Mycobacterium tuberculosis infections |
| WO2017179611A1 (ja) | 2016-04-13 | 2017-10-19 | 株式会社Ｌｓｉメディエンス | 硫酸化多糖類を用いた免疫学的測定法 |
| US10981976B2 (en) | 2016-08-31 | 2021-04-20 | University Of Rochester | Human monoclonal antibodies to human endogenous retrovirus K envelope (HERV-K) and use thereof |
| WO2020045162A1 (ja) * | 2018-08-30 | 2020-03-05 | 学校法人慶應義塾 | 薬物送達用担体 |
| JP7768735B2 (ja) * | 2021-11-16 | 2025-11-12 | 新田ゼラチン株式会社 | 生体吸収性粒子 |
| WO2025212191A1 (en) * | 2024-04-01 | 2025-10-09 | Vitakey Inc. | Heat-treated extended-release formulations |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2507193A (en) | 1949-05-17 | 1950-05-09 | Bristol Lab Inc | Penicillin product |
| US2882203A (en) | 1951-06-26 | 1959-04-14 | Novo Terapeutisk Labor As | Injectable insulin preparation with protracted effect |
| US2741573A (en) | 1953-12-28 | 1956-04-10 | Abbott Lab | Penicillin compositions for intramuscular injection |
| US3676557A (en) | 1971-03-02 | 1972-07-11 | Endo Lab | Long-acting narcotic antagonist formulations |
| JPS5416979B2 (https=) | 1972-01-08 | 1979-06-26 | ||
| US4352883A (en) * | 1979-03-28 | 1982-10-05 | Damon Corporation | Encapsulation of biological material |
| US4400391A (en) * | 1980-01-09 | 1983-08-23 | The United States Of America As Represented By The Secretary Of Agriculture | Controlled release of bioactive materials using alginate gel beads |
| US4789516A (en) | 1983-04-15 | 1988-12-06 | Damon Biotech, Inc | Production of sustained released system |
| US4690682A (en) | 1983-04-15 | 1987-09-01 | Damon Biotech, Inc. | Sustained release |
| US4744933A (en) | 1984-02-15 | 1988-05-17 | Massachusetts Institute Of Technology | Process for encapsulation and encapsulated active material system |
| CA1215922A (en) | 1984-05-25 | 1986-12-30 | Connaught Laboratories Limited | Microencapsulation of living tissue and cells |
| US4695463A (en) | 1985-05-24 | 1987-09-22 | Warner-Lambert Company | Delivery system for active ingredients and preparation thereof |
| GB2186485B (en) * | 1986-02-13 | 1988-09-07 | Ethical Pharma Ltd | Slow release formulation |
| US4933185A (en) * | 1986-09-24 | 1990-06-12 | Massachusetts Institute Of Technology | System for controlled release of biologically active compounds |
| JPH04502768A (ja) | 1989-01-26 | 1992-05-21 | アボット バイオテク，インコーポレイテッド | 疎水性蛋白質水溶液の安定化及び持続的放出ビヒクル |
| US5007790A (en) | 1989-04-11 | 1991-04-16 | Depomed Systems, Inc. | Sustained-release oral drug dosage form |
| US5175093A (en) * | 1989-11-07 | 1992-12-29 | Lehigh University | Bioactive cells immobilized in alginate beads containing voids formed with polyethylene glycol |
| US5215758A (en) | 1991-09-11 | 1993-06-01 | Euroceltique, S.A. | Controlled release matrix suppository for pharmaceuticals |
| US5192802A (en) * | 1991-09-25 | 1993-03-09 | Mcneil-Ppc, Inc. | Bioadhesive pharmaceutical carrier |
| EP0610441A4 (en) * | 1991-10-29 | 1996-01-10 | Clover Cons Ltd | CROSSLINKABLE POLYSACCHARIDES, POLYCATIONS AND LIPIDS CAN BE USED TO ENCODE AND DISPENSE MEDICINAL PRODUCTS. |
| US5656297A (en) | 1992-03-12 | 1997-08-12 | Alkermes Controlled Therapeutics, Incorporated | Modulated release from biocompatible polymers |
| US5711968A (en) | 1994-07-25 | 1998-01-27 | Alkermes Controlled Therapeutics, Inc. | Composition and method for the controlled release of metal cation-stabilized interferon |
| US5709854A (en) | 1993-04-30 | 1998-01-20 | Massachusetts Institute Of Technology | Tissue formation by injecting a cell-polymeric solution that gels in vivo |
| NZ260909A (en) | 1993-07-05 | 1995-04-27 | Takeda Chemical Industries Ltd | Production of sustained release preparation by allowing a water-soluble polypeptide to permeate into a biodegradable matrix in an aqueous solution |
| US5451411A (en) * | 1993-10-15 | 1995-09-19 | University Of Washington | Methods and compositions for the oral delivery of therapeutic agents |
| JPH10503179A (ja) | 1994-06-24 | 1998-03-24 | イミュネックス・コーポレーション | 放出制御性ポリペプチド組成物および炎症性腸疾患の治療方法 |
| US5629184A (en) | 1995-01-25 | 1997-05-13 | Amgen Inc. | Cationic copolymers of vinylamine and vinyl alcohol for the delivery of oligonucleotides |
| AU6242096A (en) | 1995-06-27 | 1997-01-30 | Takeda Chemical Industries Ltd. | Method of producing sustained-release preparation |
| EP0877627A1 (en) | 1996-01-25 | 1998-11-18 | Eli Lilly And Company | Obesity protein analog compounds and formulations thereof |
| AU1838797A (en) | 1996-02-06 | 1997-08-28 | Eli Lilly And Company | Obesity protein compounds and formulations thereof |
-
1997
- 1997-04-17 US US08/842,756 patent/US6656508B2/en not_active Expired - Fee Related
-
1998
- 1998-04-14 WO PCT/US1998/007566 patent/WO1998046211A1/en not_active Ceased
- 1998-04-14 JP JP54424798A patent/JP2001524084A/ja not_active Ceased
- 1998-04-14 EP EP98915592A patent/EP0975333B1/en not_active Expired - Lifetime
- 1998-04-14 ZA ZA983089A patent/ZA983089B/xx unknown
- 1998-04-14 CA CA002286092A patent/CA2286092C/en not_active Expired - Fee Related
- 1998-04-14 ES ES98915592T patent/ES2283052T3/es not_active Expired - Lifetime
- 1998-04-14 DK DK98915592T patent/DK0975333T3/da active
- 1998-04-14 DE DE69837140T patent/DE69837140T2/de not_active Expired - Fee Related
- 1998-04-14 AU AU69734/98A patent/AU6973498A/en not_active Abandoned
- 1998-04-14 PT PT98915592T patent/PT975333E/pt unknown
- 1998-04-14 TW TW087105641A patent/TW577755B/zh not_active IP Right Cessation
- 1998-04-14 AT AT98915592T patent/ATE354351T1/de not_active IP Right Cessation